Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangdong Bangmin Pharmaceutical Co., Ltd. (BPM), established in 1959 and reformed as a joint venture in 2001, is a comprehensive pharmaceutical enterprise based in Jiangmen, Guangdong, China. The company specializes in the R&D, production, and marketing of a wide range of medications, including cardiovascular drugs, antibiotics (cephalosporins and penicillins), and traditional Chinese medicine (TCM) derivatives. Notable products include the nationally pioneering ATP Enteric-coated tablets and Xinmaitong tablets for hypertension, alongside a broad range of third-generation cephalosporins and neuroprotective agents. Operating multiple GMP-certified production facilities and its own provincial-level engineering research center, Bangmin Pharmaceutical serves as a key manufacturing hub for anti-infective and cardiovascular therapies in the Greater Bay Area.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Bangmin Pharmaceutical.